ClinicalTrialExchange
  • Home
  • For Patients
  • For Professionals
  • About
  • Contact

Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Diabetes Insipidus, Neurogenic

  • Effects of Intranasal Oxytocin on Sexual Well-Being in Patients With Arginine Vasopressin Deficiency and Healthy Controls
  • Plasma Oxytocin Changes in Response to Low-dose MDMA vs. Placebo in Patients With Arginine Vasopressin Deficiency and Healthy Controls
  • Effect of Intranasal Oxytocin on Emotion Recognition and Acute Psycho-Social Stress-induced Cortisol Increase in Patients With Central Diabetes Insipidus and Healthy Controls
  • Identifying Oxytocin Deficiency in Adults With Pituitary Disease
  • Oxytocin Substitution Therapy in Patients With Central Diabetes Insipidus
  • Identification and Clinical Relevance of an Oxytocin Deficient State (CRH Study)
  • Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)
  • Effects of Intranasal Oxytocin in Patients With Central Diabetes Insipidus
  • Copeptin After an Oral Stimulation With Macimorelin in Healthy Volunteers
  • A Study of Minirin Melt in Japanese Patients With Central Diabetes Insipidus (CDI).
  • Study of the Pathogenesis and Pathophysiology of Familial Neurohypophyseal Diabetes Insipidus
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies

Clinical Trials data from clinicaltrials.gov

Powered by DrugPatentWatch.

  • About
  • Contact
  • Follow ClinicalTrialsExchange:

      ClinicalTrialsExchange Linkedin Group